News Roundup: March 21 to March 25
Your weekly roundup of the latest news from Drug Topics®.
APhA “Perennial Favorite” New Drug Review Covers 15 FDA Approvals
The drugs treat a range of conditions, including migraine, Alzhiemer disease, and actinic keratosis.
The Future of Pharmacy is Digital
Patients need digital pharmacists to monitor the growing armamentarium of digital therapeutics and the flood of patient-specific data.
US Drug Prices Distorted to Favor Pharmacy Benefit Managers
PBMs use hidden rebates and other strategies to rig drug pricing and sidestep regulatory efforts
APhA: Annual Pediatric, Adult Immunization Update
There’s more to vaccines than just COVID-19.
Read more
OTC Update Reviews New Products, Recalls Since 2020
Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
